Incidence of Mortality and Complications After Lung Surgery, Open Thoracic Aortic Repair, TEVAR, EVAR.

October 23, 2021 updated by: Mahidol University

Incidence of Perioperative Mortality and Major Complications in Patients Who Underwent Lung Surgery, Open Thoracic Aortic Repair, Thoracic Endovascular Aortic Repair (TEVAR), and Endovascular Aortic Repair (EVAR). A Retrospective Study

Lung surgery, open aortic surgery, TEVAR, and EVAR are major operations that carry a higher incidence of perioperative mortality and complications compare to other surgery. The study of the incidence of mortality and complications will help the hospital to benchmark with the others. Also the study of the risk factors of mortality and major complications will help to improve the patients' outcomes.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

2224

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Bangkok
      • Bangkoknoi, Bangkok, Thailand, 10700

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients who underwent one of these types of surgery 1) thoracic surgery, 2) open thoracic aortic surgery, 3) TEVAR and 4) EVAR

Description

Inclusion Criteria:

Patients underwent

  • thoracic surgery
  • open thoracic aortic surgery
  • TEVAR
  • EVAR

Exclusion Criteria:

  • Emergency lung surgery
  • Conversion from TEVAR to open thoracic surgery
  • Conversion from EVAR to open aortic surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Family-Based
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Lung surgery
Patients underwent lung surgery.
Patients underwent lung surgery including wedge resection, lobectomy, segmentectomy, and pneumonectomy.
Open aortic suregry
Patients underwent open aortic surgery.
Patients underwent open thoracic surgery or thoracoabdominal aortic surgery.
Thoracic endovascular aortic repair (TEVAR)
Patients underwent TEVAR.
Patients underwent TEVAR.
Endovascular aneurysm repair (EVAR)
Patients underwent EVAR.
Patients underwent EVAR.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of mortality and major complications after lung surgery
Time Frame: 30 days
The mortality and major complications (CVS, CNS, RS and others) will be recorded.
30 days
Incidence of mortality and major complications after open aortic surgery
Time Frame: 30 days
The mortality and major complications (CVS, CNS, RS and others) will be recorded.
30 days
Incidence of mortality and major complications after TEVAR
Time Frame: 30 days
The mortality and major complications (CVS, CNS, RS and others) will be recorded.
30 days
Incidence of mortality and major complications after EVAR
Time Frame: 30 days
The mortality and major complications (CVS, CNS, RS and others) will be recorded.
30 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Risk factors of mortality and major complications after lung surgery
Time Frame: 30 days
To identify risk factors eg. smoking, type of surgery, age, etc.
30 days
Risk factors of mortality and major complications after open aortic surgery
Time Frame: 30 days
To identify risk factors eg. smoking, type of surgery, age, etc.
30 days
Risk factors of mortality and major complications after TEVAR
Time Frame: 30 days
To identify risk factors eg. smoking, diagnosis, age, etc.
30 days
Risk factors of mortality and major complications after EVAR
Time Frame: 30 days
To identify risk factors eg. smoking, age, etc.
30 days

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of postoperative delirium
Time Frame: 30 days
The patients with postoperative delirium required treatment will be described.
30 days
Incidence of low muscle mass
Time Frame: 7 days

Psoas muscle index will be used for the diagnosis of low muscle mass. Psoas muscle index = both psoas muscle area at L3 (from CT scan) divided by body surface area.

Cut-off values of sarcopenia

  • Male 68.5 cm2/m2
  • Female 52.5 cm2/m2
7 days
Risk factors of postoperative stroke.
Time Frame: 30 days
To identify risk factors eg. smoking, type of surgery, age, etc.
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 23, 2021

Primary Completion (Anticipated)

December 31, 2023

Study Completion (Anticipated)

December 31, 2023

Study Registration Dates

First Submitted

October 2, 2021

First Submitted That Met QC Criteria

October 2, 2021

First Posted (Actual)

October 12, 2021

Study Record Updates

Last Update Posted (Actual)

November 1, 2021

Last Update Submitted That Met QC Criteria

October 23, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lung Cancer

Clinical Trials on Lung surgery

3
Subscribe